A protein called DUX4, normally active only during early development, probably damages FSHD-affected muscle fibers and could become a target for drug development
posted on October 29, 2010 - 11:00am
Little by little, the molecular underpinnings of facioscapulohumeral muscular dystrophy (FSHD) are yielding to scientific investigations. The latest revelations about a protein known as DUX4, announced in October, could bring a treatment for FSHD closer to the clinic.
About recent FSHD research